23 results on '"Sheng, Jiyao"'
Search Results
2. Precision diagnosis of hepatocellular carcinoma.
- Author
-
Wang, Zhenxiao, Qin, Hanjiao, Liu, Shui, Sheng, Jiyao, and Zhang, Xuewen
- Published
- 2023
- Full Text
- View/download PDF
3. Astragaloside in cancer chemoprevention and therapy.
- Author
-
Wang, Yaning, Zhang, Zhuo, Cheng, Zhaohua, Xie, Wei, Qin, Hanjiao, and Sheng, Jiyao
- Published
- 2023
- Full Text
- View/download PDF
4. Advances in Renal Cell Carcinoma Drug Resistance Models.
- Author
-
Xiang, Yien, Zheng, Ge, Zhong, Jianfeng, Sheng, Jiyao, and Qin, Hanjiao
- Subjects
DRUG resistance ,RENAL cancer ,OVERALL survival ,CELL culture ,CELL lines - Abstract
Renal cell carcinoma (RCC) is the most common form of kidney cancer. Systemic therapy is the preferred method to eliminate residual cancer cells after surgery and prolong the survival of patients with inoperable RCC. A variety of molecular targeted and immunological therapies have been developed to improve the survival rate and prognosis of RCC patients based on their chemotherapy-resistant properties. However, owing to tumor heterogeneity and drug resistance, targeted and immunological therapies lack complete and durable anti-tumor responses; therefore, understanding the mechanisms of systemic therapy resistance and improving clinical curative effects in the treatment of RCC remain challenging. In vitro models with traditional RCC cell lines or primary cell culture, as well as in vivo models with cell or patient-derived xenografts, are used to explore the drug resistance mechanisms of RCC and screen new targeted therapeutic drugs. Here, we review the established methods and applications of in vivo and in vitro RCC drug resistance models, with the aim of improving our understanding of its resistance mechanisms, increasing the efficacy of combination medications, and providing a theoretical foundation for the development and application of new drugs, drug screening, and treatment guidelines for RCC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Multi-label feature selection method based on dynamic weight.
- Author
-
Zhang, Ping, Sheng, Jiyao, Gao, Wanfu, Hu, Juncheng, and Li, Yonghao
- Subjects
FEATURE selection ,INFORMATION theory - Abstract
Multi-label feature selection attracts considerable attention from multi-label learning. Information theory-based multi-label feature selection methods intend to select the most informative features and reduce the uncertain amount of information of labels. Previous methods regard the uncertain amount of information of labels as constant. In fact, as the classification information of the label set is captured by features, the remaining uncertainty of each label is changing dynamically. In this paper, we categorize labels into two groups: One contains the labels with few remaining uncertainty, which means that most of classification information with respect to the labels has been obtained by the already-selected features; another group contains the labels with extensive remaining uncertainty, which means that the classification information of these labels is neglected by already-selected features. Feature selection aims to select the new features that are highly relevant to the labels in the second group. Existing methods do not distinguish the difference between two label groups and ignore the dynamic change amount of information of labels. To this end, a Relevancy Ratio is designed to clarify the dynamic change amount of information of each label under the condition of the already-selected features. Afterward, a Weighted Feature Relevancy is defined to evaluate the candidate features. Finally, a new multi-label feature selection method based on Weighted Feature Relevancy (WFRFS) is proposed. The experiments obtain encouraging results of WFRFS in comparison with six multi-label feature selection methods on thirteen real-world data sets. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Dual‐Functional Photocatalysis for Cooperative Hydrogen Evolution and Benzylamine Oxidation Coupling over Sandwiched‐Like Pd@TiO2@ZnIn2S4 Nanobox.
- Author
-
She, Ping, Qin, Jun‐sheng, Sheng, Jiyao, Qi, Yuanyuan, Rui, Hongbang, Zhang, Wei, Ge, Xin, Lu, Geyu, Song, Xiaowei, and Rao, Heng
- Published
- 2022
- Full Text
- View/download PDF
7. Bioinspired spike-like double yolk–shell structured TiO2@ZnIn2S4 for efficient photocatalytic CO2 reduction.
- Author
-
She, Ping, Guan, Buyuan, Sheng, Jiyao, Qi, Yuanyuan, Qiao, Guanyu, Rui, Hongbang, Lu, Geyu, Qin, Jun-Sheng, and Rao, Heng
- Published
- 2022
- Full Text
- View/download PDF
8. Mitochondrial Quality Control in Hepatocellular Carcinoma.
- Author
-
Bian, Jinda, Zhang, Dan, Wang, Yicun, Qin, Hanjiao, Yang, Wei, Cui, Ranji, and Sheng, Jiyao
- Subjects
QUALITY control ,HEPATOCELLULAR carcinoma ,OVERALL survival ,MITOCHONDRIA ,HOMEOSTASIS - Abstract
Mitochondria participate in the progression of hepatocellular carcinoma (HCC) by modifying processes including but not limited to redox homeostasis, metabolism, and the cell death pathway. These processes depend on the health status of the mitochondria. Quality control processes in mitochondria can repair or eliminate "unhealthy mitochondria" at the molecular, organelle, or cellular level and form an efficient integrated network that plays an important role in HCC tumorigenesis, patient survival, and tumor progression. Here, we review the influence of mitochondria on the biological behavior of HCC. Based on this information, we further highlight the need for determining the role and mechanism of interaction between different levels of mitochondrial quality control in regulating HCC occurrence and progression as well as resistance development. This information may lead to the development of precision medicine approaches against targets involved in various mitochondrial quality control-related pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Filamentous Bacteriophage—A Powerful Carrier for Glioma Therapy.
- Author
-
Wang, Yicun, Sheng, Jiyao, Chai, Jin, Zhu, Cuilin, Li, Xin, Yang, Wei, Cui, Ranji, and Ge, Tongtong
- Subjects
GLIOMAS ,BACTERIOPHAGES ,DISEASE relapse ,BLOOD-brain barrier ,DRUG therapy ,BRAIN tumors - Abstract
Glioma is a life-threatening malignant tumor. Resistance to traditional treatments and tumor recurrence present major challenges in treating and managing this disease, consequently, new therapeutic strategies must be developed. Crossing the blood-brain barrier (BBB) is another challenge for most drug vectors and therapy medications. Filamentous bacteriophage can enter the brain across the BBB. Compared to traditional drug vectors, phage-based drugs offer thermodynamic stability, biocompatibility, homogeneity, high carrying capacity, self-assembly, scalability, and low toxicity. Tumor-targeting peptides from phage library and phages displaying targeting peptides are ideal drug delivery agents. This review summarized recent studies on phage-based glioma therapy and shed light on the developing therapeutics phage in the personalized treatment of glioma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries.
- Author
-
Wu, Jun, Sheng, Jiyao, Qin, Hanjiao, Cui, Mengying, Yang, Yongsheng, and Zhang, Xuewen
- Subjects
XENOGRAFTS ,CHOLANGIOCARCINOMA ,CANCER chemotherapy ,PROGNOSIS ,ADJUVANT chemotherapy ,ANTINEOPLASTIC agents - Abstract
Surgical treatment is the only possible cure for cholangiocarcinoma (CCA) at present. However, the high recurrence rate of postoperative CCA leads to a very poor prognosis for patients, effective postoperative chemotherapy is hence the key to preventing the recurrence of CCA. The sensitivity of CCA to cytotoxic chemotherapy drugs and targeted drugs varies from person to person, and therefore, the screening of sensitive drugs has become an important topic after CCA surgeries. Patient-Derived tumor Xenograft models (PDX) can stably retain the genetic and pathological characteristics of primary tumors, and better simulate the tumor microenvironment of CCA. The model is also of great significance in screening therapeutic targeted drugs after CCA, analyzing predictive biomarkers, and improving signal pathways in prognosis and basic research. This paper will review the current established methods and applications of the patient-derived tumor xenograft model of cholangiocarcinoma, aiming to provide new ideas for basic research and individualized treatment of cholangiocarcinoma after surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications.
- Author
-
Cao, Lidong, Wu, Jiacheng, Qu, Xianzhi, Sheng, Jiyao, Cui, Mengying, Liu, Shui, Huang, Xu, Xiang, Yien, Li, Bingjin, Zhang, Xuewen, and Cui, Ranji
- Abstract
Pancreatic cancer is one of the most malignant tumors worldwide, and pancreatic ductal adenocarcinoma is the most common type. In pancreatic cancer, glycolysis is the primary way energy is produced to maintain the proliferation, invasion, migration, and metastasis of cancer cells, even under normoxia. However, the potential molecular mechanism is still unknown. From this perspective, this review mainly aimed to summarize the current reasonable interpretation of aerobic glycolysis in pancreatic cancer and some of the newest methods for the detection and treatment of pancreatic cancer. More specifically, we reported some biochemical parameters, such as newly developed enzymes and transporters, and further explored their potential as diagnostic biomarkers and therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
- Author
-
Lin, Chao, Xiang, Yien, Sheng, Jiyao, Liu, Shui, Cui, Mengying, and Zhang, Xuewen
- Abstract
Emerging evidence has suggested that long non-coding RNA (lncRNA) colorectal neoplasia differentially expressed (CRNDE) is upregulated in hepatocellular carcinoma (HCC) and is associated with cell invasion, migration, and growth. However, the potential modulation mechanism remains to be elucidated. MiR-33a-5p and cyclin-dependent kinase 6 (CDK6) also participate in the pathophysiology of HCC. This work aims to investigate the effect of CRNDE on HCC apoptosis, invasion, and migration and elucidate the role of miR-33a-5p and CDK6 therein. CRNDE and CDK6 were upregulated in HCC tissues and cells, while miR-33a-5p was downregulated. Inhibition of CRNDE suppressed the invasion, migration, and proliferation of HCC cells and enhanced apoptosis by modulating proteins associated with mitochondrial apoptosis (caspase 3, Bax, cytochrome-c, Bcl-2), which were the same as the function of miR-33a-5p overexpression. The dual-luciferase reporter assay demonstrated that miR-33a-5p was a target of CRNDE, and in turn, CRNDE inhibition enhanced the level of miR-33a-5p. CDK6 was also revealed as a target of miR-33a-5p, and both CRNDE inhibition and miR-33a-5p overexpression suppressed CDK6 expression and led to G0/G1 phase block in HCC cells. In vivo experiments using a mouse xenograft tumor model further verified the interaction between CRNDE and miR-33a-5p, showing that miR-33a-5p overexpression or CRNDE inhibition suppressed CDK6 expression and HCC tumorigenesis. Overall, the present work indicated that CRNDE plays an oncogenic function in HCC through regulating the miR-33a-5p/CDK6 axis, revealing a potential therapeutic target in HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review.
- Author
-
Zhang, Chaohe, Sheng, Jiyao, Li, Guangquan, Zhao, Lihong, Wang, Yicun, Yang, Wei, Yao, Xiaoxiao, Sun, Lihuan, Zhang, Zhuo, and Cui, Ranji
- Subjects
BERBERINE ,PHARMACOLOGY ,BIOCHEMICAL mechanism of action ,DRUG therapy ,CANCER treatment - Abstract
Numerous studies have shown that berberine and its derivatives demonstrate important anti-tumor effects. However, the specific underlying mechanism remains unclear. Therefore, based on systems pharmacology, this review summarizes the information available on the anti-tumor effects and mechanism of berberine and its derivatives. The action and potential mechanism of action of berberine and its derivatives when used in the treatment of complex cancers are systematically examined at the molecular, cellular, and organismic levels. It is concluded that, with further in-depth investigations on their toxicity and efficacy, berberine and its derivatives have the potential for use as drugs in cancer therapy, offering improved clinical efficacy and safety. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial‐lysosomal crosstalk.
- Author
-
Sheng, Jiyao, Shen, Luyan, Sun, Liankun, Zhang, Xuewen, Cui, Ranji, and Wang, Lizhong
- Subjects
LYSOSOMES ,HEPATOCELLULAR carcinoma ,CROSSTALK ,NUCLEAR DNA ,MITOCHONDRIAL membranes ,MEMBRANE potential - Abstract
Objectives: The genotoxicity of cisplatin towards nuclear DNA is not sufficient to explain the cisplatin resistance of hepatocellular carcinoma (HCC) cells; cisplatin interacts with many organelles, which can influence the sensitivity. Here, we explored the role of mitochondrial‐lysosomal crosstalk in the cisplatin resistance of HCC cells. Materials and methods: Huh7 and HepG2 cells were subjected to different treatments. Flow cytometry was conducted to detect mitochondrial reactive oxygen species, mitochondrial mass, lysosomal function, mitochondrial membrane potential and apoptosis. Western blotting was performed to evaluate protein levels. The oxygen consumption rate was measured to evaluate mitochondrial function. Results: Cisplatin activated mitophagy and lysosomal biogenesis, resulting in crosstalk between mitochondria and lysosomes and cisplatin resistance in HCC cells. Furthermore, a combination of cisplatin with the phosphatidylinositol‐3‐kinase/mammalian target of rapamycin (PI3K/mTOR) inhibitor PKI‐402 induced lysosomal membrane permeabilization. This effect changed the role of the lysosome from a protective one to that of a cell death promoter, completely destroying the mitochondrial‐lysosomal crosstalk and significantly enhancing the sensitivity of HCC cells to cisplatin. Conclusions: This is the first evidence of the importance of mitochondrial‐lysosomal crosstalk in the cisplatin resistance of HCC cells and of the destruction of this crosstalk by a PI3K/mTOR inhibitor to increase the sensitivity of HCC cells to cisplatin. This mechanism could be developed as a novel target for treatment of HCC in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. Recent Advances in Herbal Medicines for Digestive System Malignancies.
- Author
-
Sheng, Jiyao, Zou, Xiaohan, Cheng, Ziqian, Xiang, Yien, Yang, Wei, Lin, Yang, and Cui, Ranji
- Abstract
Herbal medicines, as an important part of traditional Chinese medicine (TCM), have been used to treat digestive system malignancies (DSM) for many years, and have gradually gained recognition worldwide. The role of herbal medicines in the comprehensive treatment of DSM is being improved from adjuvant treatment of the autologous immune function in cancer patients, to the treatment of both the symptoms and disease, direct inhibition of tumor cell growth and proliferation, and induction of tumor cell autophagy and apoptosis. Their specific mechanisms in these treatments are also being explored. The paper reviews the current anti-tumor mechanisms of TCM, including single herbal medicines, Chinese herbal formulations, Chinese medicine preparations and TCM extract, and their application in the comprehensive treatment of digestive system tumors, providing a reference for clinical application of TCM. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
16. Sarcomatoid carcinoma of the pancreas: A case report and review of the literature.
- Author
-
Xie, Yingjun, Xiang, Yien, Zhang, Dan, Yao, Xiaoxiao, Sheng, Jiyao, Yang, Yongsheng, and Zhang, Xuewen
- Subjects
PANCREATIC cancer ,OLDER men ,BILE ducts ,CANCER invasiveness ,LIVER metastasis ,EPITHELIAL cells - Abstract
Sarcomatoid carcinoma (SC) is an extremely rare and complicated malignant neoplasm that consists of both malignant epithelial components and atypical spindle cells that express an epithelial phenotype. The presents study reported a case of SC of the pancreas (SCP), along with a brief review of the literature. A 63-year-old man was admitted to The Second Hospital of Jilin University hospital with complaints of epigastralgia and jaundice of one month in duration. Based on preoperative laboratory blood tests and radiography, a mass at the distal common bile duct was suspected. Intraoperative examination discovered a 2.5×2×1.8-cm mass in the pancreatic head, with invasion of the distal bile duct. Pancreaticoduodectomy was performed. Histopathology and immunohistochemistry of the specimen confirmed the diagnosis of SCP. The patient succumbed 18 months after surgery due to multiple hepatic metastases. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
17. Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma.
- Author
-
Liu, Shui, Yao, Xiaoxiao, Zhang, Dan, Sheng, Jiyao, Wen, Xin, Wang, Qingyu, Chen, Gaoyang, Li, Zhaoyan, Du, Zhenwu, and Zhang, Xuewen
- Subjects
HEPATOCELLULAR carcinoma ,CANCER invasiveness ,CELLULAR signal transduction ,METABOLISM ,POLYMERASE chain reaction ,TRANSCRIPTION factors ,BIOINFORMATICS ,DISEASE progression ,GENE expression profiling ,GENETICS - Abstract
Hepatocellular carcinoma (HCC) accounts for a significant proportion of liver cancer, which has become the second most common cause of cancer-related mortality worldwide. To investigate the potential mechanisms of invasion and progression of HCC, bioinformatics analysis and validation by qRT-PCR were performed. We found 237 differentially expressed genes (DEGs) including EGR1, FOS, and FOSB, which were three cancer-related transcription factors. Subsequently, we constructed TF-gene network and miRNA-TF-mRNA network based on data obtained from mRNA and miRNA expression profiles for analysis of HCC. We found that 42 key genes from the TF-gene network including EGR1, FOS, and FOSB were most enriched in the p53 signaling pathway. The qRT-PCR data confirmed that mRNA levels of EGR1, FOS, and FOSB all were decreased in HCC tissues. In addition, we confirmed that the mRNA levels of CCNB1, CCNB2, and CHEK1, three key markers of the p53 signaling pathway, were all increased in HCC tissues by bioinformatics analysis and qRT-PCR validation. Therefore, we speculated that miR-181a-5p, which was upregulated in HCC tissues, could regulate FOS and EGR1 to promote the invasion and progression of HCC by p53 signaling pathway. Overall, the study provides support for the possible mechanisms of progression in HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
18. PGC1α promotes cisplatin resistance in human ovarian carcinoma cells through upregulation of mitochondrial biogenesis.
- Author
-
Shen, Luyan, Sun, Boyang, Sheng, Jiyao, Yu, Sihang, Li, Yanqing, Xu, Huadan, Su, Jing, and Sun, Liankun
- Published
- 2018
- Full Text
- View/download PDF
19. Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.
- Author
-
Xie, Yingjun, Xiang, Yien, Sheng, Jiyao, Zhang, Dan, Yao, Xiaoxiao, Yang, Yongsheng, and Zhang, Xuewen
- Subjects
LIVER cancer ,IMMUNOTHERAPY ,CANCER invasiveness ,TREATMENT effectiveness ,PATIENT safety ,TUMOR treatment ,THERAPEUTIC use of monoclonal antibodies ,BIOTHERAPY ,CELL receptors ,CELLULAR signal transduction ,HEPATOCELLULAR carcinoma ,IMMUNITY ,IMMUNOLOGICAL tolerance ,LIVER tumors ,T cells ,TUMOR antigens ,CANCER vaccines ,THERAPEUTICS - Abstract
Primary liver cancer is a common kind of digestive cancers with high malignancy, causing 745,500 deaths each year. Hepatocellular carcinoma is the major pathological type of primary liver cancer. Traditional treatment methods for patients with hepatocellular carcinoma have shown poor efficacy in killing residual cancer cells for a long time. In recent years, tumor immunotherapy has emerged as a promising method owing to its safety and efficacy with respect to delaying the progression of advanced tumors and protecting postoperative patients against tumor relapse and metastasis. Immune tolerance and suppression in tumor microenvironments are the theoretical basis of immunotherapy. Adoptive cell therapy functions by stimulating and cultivating autologous lymphocytes ex vivo and then reinfusing them into the patient to kill cancer cells. Cancer vaccination is performed using antigenic substances to activate tumor-specific immune responses. Immune checkpoint inhibitors can reactivate tumor-specific T cells and develop an antitumor effect by suppressing checkpoint-mediated signaling. Oncolytic viruses may selectively replicate in tumor cells and cause lysis without harming normal tissues. Here, we briefly introduce the mechanism of immunosuppression in hepatocellular carcinoma and summarize the rationale of the four major immunotherapeutic approaches with their current advances. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
20. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.
- Author
-
Sheng, Jiyao, Liu, Shui, Cui, Ranji, Zhang, Xuewen, and Wang, Yicun
- Subjects
CHRONIC pain ,MENTAL depression ,NEUROPLASTICITY ,NOCICEPTIVE pain ,MENTAL illness - Abstract
Chronic pain, as a stress state, is one of the critical factors for determining depression, and their coexistence tends to further aggravate the severity of both disorders. Unfortunately, their association remains unclear, which creates a bottleneck problem for managing chronic pain-induced depression. In recent years, studies have found considerable overlaps between pain- and depression-induced neuroplasticity changes and neurobiological mechanism changes. Such overlaps are vital to facilitating the occurrence and development of chronic pain and chronic pain-induced depression. In this review, we summarized the role of neuroplasticity in the occurrence and development of the two disorders in question and explored individualized application strategies of analgesic drugs and antidepressants that have different pharmacological effects in the treatment of chronic pain-induced depression. Therefore, this review may provide new insights into the understanding of association between chronic pain and depression. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
- Author
-
Qu, Xianzhi, Sheng, Jiyao, Shen, Luyan, Su, Jing, Xu, Yunjie, Xie, Qi, Wu, Yao, Zhang, Xuewen, and Sun, Liankun
- Subjects
CHOLANGIOCARCINOMA ,CISPLATIN ,AUTOPHAGY ,CHLOROQUINE ,CANCER cells ,REACTIVE oxygen species ,GLUCOSE metabolism ,DRUG resistance in cancer cells ,THERAPEUTICS - Abstract
The tumor cells have some metabolic characteristics of the original tissues, and the metabolism of the tumor cells is closely related to autophagy. However, the mechanism of autophagy and metabolism in chemotherapeutic drug resistance is still poorly understood. In this study, we investigated the role and mechanism of autophagy and glucose metabolism in chemotherapeutic drug resistance by using cholangiocarcinoma QBC939 cells with primary cisplatin resistance and hepatocellular carcinoma HepG2 cells. We found that QBC939 cells with cisplatin resistance had a higher capacity for glucose uptake, consumption, and lactic acid generation, and higher activity of the pentose phosphate pathway compared with HepG2 cells, and the activity of PPP was further increased after cisplatin treatment in QBC939 cells. It is suggested that there are some differences in the metabolism of glucose in hepatocellular carcinoma and cholangiocarcinoma cells, and the activation of PPP pathway may be related to the drug resistance. Through the detection of autophagy substrates p62 and LC3, found that QBC939 cells have a higher flow of autophagy, autophagy inhibitor chloroquine can significantly increase the sensitivity of cisplatin in cholangiocarcinoma cells compared with hepatocellular carcinoma HepG2 cells. The mechanism may be related to the inhibition of QBC939 cells with higher activity of the PPP, the key enzyme G6PDH, which reduces the antioxidant capacity of cells and increases intracellular ROS, especially mitochondrial ROS. Therefore, we hypothesized that autophagy and the oxidative stress resistance mediated by glucose metabolism may be one of the causes of cisplatin resistance in cholangiocarcinoma cells. It is suggested that according to the metabolism characteristics of tumor cells, inhibition of autophagy lysosome pathway with chloroquine may be a new route for therapeutic agents against cholangiocarcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. A Novel Deep Blue LE-Dominated HLCT Excited State Design Strategy and Material for OLED.
- Author
-
Tian, Xuzhou, Sheng, Jiyao, Zhang, Shitong, Xiao, Shengbing, Gao, Ying, Liu, Haichao, and Yang, Bing
- Subjects
LIGHT emitting diodes ,EXCITED states ,QUANTUM efficiency ,MOLECULAR spectra ,ORGANIC light emitting diodes - Abstract
Deep blue luminescent materials play a crucial role in the organic light-emitting diodes (OLEDs). In this work, a novel deep blue molecule based on hybridized local and charge-transfer (HLCT) excited state was reported with the emission wavelength of 423 nm. The OLED based on this material achieved high maximum external quantum efficiency (EQE) of 4% with good color purity. The results revealed that the locally-excited (LE)-dominated HLCT excited state had obvious advantages in short wavelength and narrow spectrum emission. What is more, the experimental and theoretical combination was used to describe the excited state characteristic and to understand photophysical property. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. High-throughput screen of essential gene modules in Mycobacterium tuberculosis: a bibliometric approach.
- Author
-
Xu, Guangyu, Liu, Bin, Wang, Fang, Wei, Chengguo, Zhang, Ying, Sheng, Jiyao, Wang, Guoqing, and Li, Fan
- Abstract
Background: Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis). The annotation of functional genome and signaling network in M. tuberculosis are still not systematic. Essential gene modules are a collection of functionally related essential genes in the same signaling or metabolic pathway. The determination of essential genes and essential gene modules at genomic level may be important for better understanding of the physiology and pathology of M. tuberculosis, and also helpful for the development of drugs against this pathogen. The establishment of genomic operon database (DOOR) and the annotation of gene pathways have felicitated the genomic analysis of the essential gene modules of M. tuberculosis.Method: Bibliometric approach has been used to perform a High-throughput screen for essential genes of M. tuberculosis strain H37Rv. Ant colony algorithm were used to identify the essential genes in other M. tuberculosis reference strains. Essential gene modules were analyzed by operon database DOOR. The pathways of essential genes were assessed by Biocarta, KEGG, NCI-PID, HumanCyc and Reactome. The function prediction of essential genes was analyzed by Pfam.Results: A total approximately 700 essential genes were identified in M. tuberculosis genome. 40% of operons are consisted of two or more essential genes. The essential genes were distributed in 92 pathways in M. tuberculosis. In function prediction, 61.79% of essential genes were categorized into virulence, intermediary metabolism/respiration, cell wall related and lipid metabolism, which are fundamental functions that exist in most bacteria species.Conclusion: We have identified the essential genes of M. tuberculosis using bibliometric approach at genomic level. The essential gene modules were further identified and analyzed. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.